Chemoinformaics analysis of CHRYSANTHEMIC-ACID-ESTER
| Molecular Weight | 254.241 | nRot | 0 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 18 |
| Exact Molecular Weight | 254.058 | nRing | 3 |
| Solubility: LogS | -5.85 | nHRing | 0 |
| Solubility: LogP | 4.158 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 34.9259 |
| nHD | 2 | BPOL | 11.7681 |
| QED | 0.644 |
| Synth | 2.189 |
| Natural Product Likeliness | 1.035 |
| NR-PPAR-gamma | 0.949 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.034 |
| Pgp-sub | 0.001 |
| HIA | 0.009 |
| CACO-2 | -4.936 |
| MDCK | 0.000014 |
| BBB | 0.135 |
| PPB | 0.996354 |
| VDSS | 0.457 |
| FU | 0.00833013 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.411 |
| CYP2c19-inh | 0.279 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.636 |
| CYP2c9-sub | 0.402 |
| CYP2d6-inh | 0.537 |
| CYP2d6-sub | 0.228 |
| CYP3a4-inh | 0.599 |
| CYP3a4-sub | 0.138 |
| CL | 6.205 |
| T12 | 0.137 |
| hERG | 0.027 |
| Ames | 0.886 |
| ROA | 0.23 |
| SkinSen | 0.517 |
| Carcinogencity | 0.908 |
| EI | 0.98 |
| Respiratory | 0.072 |
| NR-Aromatase | 0.206 |
| Antiviral | Yes |
| Prediction | 0.719498 |